Facebook
Twitter
LinkedIn
Forward
Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2022
September 17, 2022
LIVE (In-Person) and LIVESTREAM (Virtual) attendance options are available.
Presented by the Sherrie and Alan Conover Center for Liver Disease & Transplantation at Houston Methodist
The epidemic of liver disease has become increasingly more common and poses complex problems regarding diagnosis and management. There are recent advances in the diagnosis and management of patients with liver disease. This CE activity has been designed to educate attendees about new developments in hepatology, and new approaches to management of liver diseases that can be readily integrated into their daily practice. A group of national experts, including several renowned guest faculty, will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders.
This course, in addition to lecture format presentations, will provide interactive instructional presentations, debate and panel discussions, Q&A sessions, case discussions and use an interactive audience response system.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (Houston Methodist) | $25 |
| Physician (Private physician located within the Greater Houston Area) | $300 |
| Physician (Private physician located outside the Greater Houston Area) | $50 |
| Allied Health Care Professional | $10 |
| Resident / Fellow / Student | Free |
Target Audience
This conference is designed for primary care physicians, internists, hepatologists, gastroenterologists, oncologists, nurses, nurse practitioners, and physician assistants and other health care providers.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Explain the current diagnosis and management of complications of portal hypertension and metabolic liver diseases
- Identify emerging trends in fatty liver disease and determine the latest concepts in diagnosis and management
- Provide significant information regarding new and critical developments in chronic HBV, HCV and COVID-19 liver involvement
- Discuss current new developments and treatment of liver cancer – an emerging epidemic
| TIME | PRESENTATION | SPEAKER(S) |
| 7:00 AM | Registration and Breakfast | |
| 7:20 AM | Welcome | Victor Ankoma-Sey, MD, FACP, FAASLD |
| 7:25 AM | Introduction | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| Plenary Session I: Unique Complications of Chronic Liver Diseases Moderators: Chukwuma Egwim, MD; Joseph S. Galati, MD; Ashish Saharia, MD, FACS | ||
| 7:30 AM | Sherilyn Gordon-Burroughs State-of-Art-Lecture I Acute-on-Chronic Liver Failure: Where Are We Now? | Hugo E. Vargas, MD |
| 8:00 AM | Hepatorenal Syndrome: Pathogenesis, Current and Future Therapies | Florence Wong, MD, FRACP, FRCPC |
| 8:30 AM | What is New in Hepatic Encephalopathy? | Jasmohan S. Bajaj, MBBS, MD, MSc, FACG, AGAF, FAASLD, FRCP |
| 9:00 AM | State of the Art Lecture I The Unique Challenges in the Management of Viral Hepatitis B and C in the Immunocompromised Patient | Norah A. Terrault, MD, MPH, FAASLD |
| 9:30 AM | Question and Answer / Case Discussions – Putting it into Practice | Chukwuma Egwim, MD; Joseph S. Galati, MD; Ashish Saharia, MD, FACS |
| 9:50 AM | Break and Exhibits | |
| Plenary Session II: Advances in Non-Alcoholic Fatty Liver Disease - What is New? Moderators: Victor Ankoma-Sey, MD, FACP, FAASLD; Constance M. Mobley, MD, PhD, FACS; David W. Victor, III, MD | ||
| 10:05 AM | Epidemiology, Pathogenesis and Natural History: 2022 Update | David W. Victor, III, MD |
| 10:35 AM | Noninvasive Assessment in Nonalcoholic Fatty Liver Disease | Mazen Noureddin, MD, MHSc |
| 11:05 AM | State of the Art Lecture II Current and Future Treatment Options | Naga P. Chalasani, MD |
| 11:35 AM | Question and Answer / Case Discussions – Putting it into Practice | Victor Ankoma-Sey, MD, FACP, FAASLD; Constance M. Mobley, MD, PhD, FACS; David W. Victor, III, MD |
| 11:55 AM | Lunch and Exhibits | |
| Plenary Session III: Innovations in Liver Transplantation Moderators: Andres Duchini, MD; R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed); Robert S. McFadden, MD | ||
| 12:25 PM | State of the Art Lecture III The Future of Liver Transplantation | Cristian Lupascu, MD, PhD |
| 12:55 PM | DEBATE PRO: XenoTransplantation: Is Liver Xenotransplantation A Viable Option | Constance M. Mobley, MD, PhD, FACS |
| 1:10 PM | DEBATE CON: XenoTransplantation: Is Liver Xenotransplantation A Viable Option | Chukwuma Egwim, MD |
| 1:25 PM | Rebuttal | |
| 1:35 PM | Living Donor Liver Transplant | Ashish Saharia, MD, FACS |
| 2:05 PM | How Can We Expand Our Pool of Liver Donors? | Mark J. Hobeika, MD, FACS |
| 2:35 PM | Question and Answer / Case Discussions – Putting it into Practice | Andres Duchini, MD; R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed); Robert S. McFadden, MD |
| 2:55 PM | Break and Exhibits | |
| Plenary Session IV: Liver Cancer - Current Concepts Moderators: Maen Abdelrahim, MD, PhD, B Pharm; Kirk E. Heyne, MD; Milind M. Javle, MD | ||
| 3:10 PM | Epidemiology, Surveillance and Diagnosis of Hepatocellular Cancer | Amit Singal, MD, MS |
| 3:40 PM | Hepatocellular Carcinoma - Current and Future Medical Options | Sudha Kodali, MD, MSPH |
| 4:10 PM | State of the Art Lecture IV Is the Management of Cholangiocarcinoma A Model for Personalized Medicine? | Lewis R. Roberts, MB CHb, PhD |
| 4:40 PM | Question and Answer / Case Discussions – Putting it into Practice | Maen Abdelrahim, MD, PhD, B Pharm; Kirk E. Heyne, MD, and Milind M. Javle, MD |
| 5:00 PM | Closing Remarks | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| 5:05 PM | Adjournment | |
LIVE (in-person) and LIVESTREAM (virtual) attendance options are available.
LIVE (in-person attendance) will be held in the Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030).
LIVESTREAM information will be provided to registered learners.
| COURSE DIRECTOR |
| Victor Ankoma-Sey, MD, FACP, FAASLD |
| Director, Liver Transplant Program Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Director, Liver Associates of Texas, PA |
| GUEST FACULTY |
| Jasmohan S. Bajaj, MBBS, MD, MSc, FACG, AGAF, FAASLD, FRCP (London) |
| Tenured Professor of Medicine and Staff Physician Virginia Commonwealth University Medical Center Central Virginia VA Healthcare System Richmond, Virginia |
| Naga P. Chalasani, MD |
| David W. Crabb Professor of Gastroenterology and Hepatology Indiana Unviersity School of Medicine Indianapolis, Indiana |
| Milind M. Javle, MD |
| Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, Texas |
| Cristian Lupascu, MD, PhD |
| Professor of Surgery, University of Medicine and Pharmacy "Gr. T. Popa" Head of Liver Transplantation Program ProgramIasi, Romania |
| Mazen Noureddine, MD, MHSc |
| Director Houston Liver Institute Houston, Texas |
| Lewis R. Roberts, MB CHb, PhD, FACP |
| Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic College of Medicine Rochester, Minnesota |
| Amit Singal, MD, MS |
| Professor of Medicine Willis C. Maddrey, M.D. Distinguished Chair in Liver Disease Chief of Hepatology and Medical Director, Liver Tumor Program UT Southwestern Medical Center Dallas, Texas |
| Norah A. Terrault, MD, MPH, FAASLD |
| Professor of Medicine Chief, Division of GI and Liver: Neil Kaplowitz Chair in Liver Diseases Keck School of Medicine of University of Southern California Los Angeles, California |
| Hugo E. Vargas, MD |
| Director of Hepatology Division of GI and Hepatology Mayo Clinic Phoenix, Arizona |
| Florence Wong, MD, FRACP, FRCPC |
| Professor of Medicine University of Toronto Toronto, Ontario, Canada |
| HOUSTON METHODIST FACULTY |
| Maen Abdelrahim, MD, PhD, B Pharm |
| Medical Director, Cockrell Center for Advanced Therapeutics, Phase I Program Gastrointestinal Medical and Transplant Oncologist Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Assistant Professor of Medicine Weill Cornell Medical College Houston Methodist |
| Andrea Duchini, MD |
| Transplant Hepatology, Hepatology, Gastroenterology Houston Methodist |
| Chukwuma Egwim, MD |
| Transplant Hepatologist Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Liver Associates of Texas, PA |
| Joseph S. Galati, MD |
| Medical Director, Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Houston Methodist Director, Liver Specialists of Texas |
| R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| J.C. Walter Jr. Presidential Distinguished Chair Director, J.C. Walter Jr. Transplant Center Director, Transplantation Research Chief, Division of Transplantation, Department of Surgery Professor of Surgery Weill Cornell Medical College Houston Methodist |
| Kirk E. Heyne, MD |
| Gastrointestinal Medical and Transplant Oncologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Assistant Professor of Medicine Houston Methodist Weill Cornell Medical College |
| Mark J. Hobeika, MD, FACS |
| Assistant Professor of Surgery, Academic Institute Assistant Clinical Member, Research Institute Houston Methodist Weill Cornell Medical College |
| Sudha Kodali, MD, MSPH |
| Transplant Hepatologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Associate Professor of Medicine Houston Methodist |
| Robert S. McFadden, MD |
| Transplant Hepatologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Assistant Professor of Medicine Houston Methodist Weill Cornell Medical College |
| Constance M. Mobley, MD, PhD, FACS |
| Associate Director of Liver Transplantation J.C. Walter Jr. Transplant Center Associate Surgical Director of Liver Transplantation Medical Director, Surgical & Liver ICU Program Director, Surgical Critical Care Fellowship Vice Chair Diversity, Equity and Community Integration Houston Methodist Department of Surgery Assistant Professor of Surgery Houston Methodist Weill Cornell Medical College Adjunct Assistant Professor Texas A&M College of Medicine |
| Ashish Saharia, MD, FACS |
| Director, Liver Transplantation Surgical Director of Liver Transplantation Transplant and Hepatobiliary Surgeon, Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Assistant Professor of Surgery Houston Methodist Weill Cornell Medical College |
| David W. Victor, III, MD |
| Transplant Hepatologist, Sherrie and Alan Conover Center for Liver Disease & Transplantation Houston Methodist J.C. Walter Jr. Transplant Center Associate Professor of Medicine Houston Methodist Weill Cornell Medical College |
Available Credit
- 8.50 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 8.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 8.66 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award 8.66 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.
- 8.00 Transplant CoordinatorsThe American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2022 | Thu, 05/12/2022 - 10:00am | 8.00 Category 1 CEPTCs
COMMERCIAL SUPPORT
We gratefully acknowledge the following company for providing an educational grant to partially support this activity:
Salix
EXHIBITORS
We gratefully acknowledge the following companies for participating as exhibitors for this activity:
AbbVie
Dynavax
Eisai
Genentech
Gilead Sciences
Mallinkrodt
Salix
Takeda Pharmaceuticals
Price
Cost:
$300.00
REGISTRATION INSTRUCTIONS
- STEP 1 - Choose the activity format you would like to attend (LIVE or LIVESTREAM) by selecting the checkbox next to the activity and clicking the "Enroll" button.
- STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (Houston Methodist) | $25 |
| Physician (Private physician located within the Greater Houston Area) | $300 |
| Physician (Private physician located outside the Greater Houston Area) | $50 |
| Allied Health Care Professional | $10 |
| Resident / Fellow / Student | Free |